Topic: Smallpox Vaccine

A surge in measles cases in the United States is attributed to declining vaccination rates in certain pockets of the population. A personal anecdote is shared regarding the onset of Tourette's syndrome following childhood vaccinations in the Netherlands, leading to a discussion on vaccine safety.

The hosts reminisce about historical vaccination methods, including the bifurcated needles used for smallpox and the compressed air "jet injectors" used for polio. They discuss the "mark" left by the smallpox vaccine and the modern shift away from aspirating needles.

Dr. Ashish Jha defended ongoing vaccine mandates by citing George Washington's 1777 order to inoculate the Continental Army against smallpox. Jha argued that local institutions and the military have a historical right to mandate health measures to ensure a "healthy fighting force." Critics challenged the comparison, noting the significant differences between 18th-century variolation and modern mRNA technology.

Dr. Ashish Jha addresses questions regarding whether childhood smallpox vaccinations provide protection against the current monkeypox outbreak, stating the data is still being reviewed. The discussion touches on the physical scars left by historical smallpox vaccines and the current uncertainty regarding immunity levels in older populations. The FDA's role in monitoring the spread and developing testing methods is also noted.

Documents suggest that the Jynneos vaccine, originally intended for smallpox, had monkeypox added to its indication in 2019 at the request of U.S. government stakeholders. The timing of this regulatory change occurs three years prior to the current outbreak, raising questions about government foresight or corruption.

ABC News Chief Medical Correspondent Dr. Jennifer Ashton detailed the transmission risks of monkeypox, emphasizing skin-to-skin contact and contaminated materials like towels. While not classified strictly as a sexually transmitted disease, the virus spreads through prolonged intimate contact. The JYNNEOS vaccine, originally approved in 2019, is being deployed despite questions regarding its specific efficacy against the current strain.

Tim Nguyen of the World Health Organization discusses the global supply of monkeypox vaccines, including the MVA-BN and ACAM2000 stockpiles. He emphasizes that the effectiveness of these vaccines in the current context is uncertain and recommends they be delivered within clinical trial frameworks. Concerns are raised regarding whether individuals receiving the shots are fully informed of their experimental status in this specific application.

Quebec health officials reported that monkeypox cases have doubled, leading to the administration of smallpox vaccines to high-risk contacts. The discussion explores the demographic spread of the virus and questions whether the symptoms are being confused with shingles or vaccine adverse events. Most cases are reported to be mild with patients expected to recover.

The term "headline risk" is analyzed in the context of economic and health reporting, referencing former press secretary Jen Psaki's comments on inflation. Historical data from the CDC indicates monkeypox was first identified in 1958 during medical experiments on monkeys, and older individuals with smallpox vaccinations may have residual immunity.

The 1905 Supreme Court case Jacobson v. Massachusetts is frequently cited as the legal foundation for mandatory vaccinations in the United States. While the court upheld the state's authority to mandate smallpox vaccines, the actual penalty for non-compliance was a five-dollar fine rather than forced injection. This historical context is used to debate the limits of government power regarding modern vaccine mandates and the potential for discriminatory practices.

The New York State Bar Association passed a resolution urging the state to consider mandatory COVID-19 vaccinations, even for those with religious or philosophical objections. The hosts debate the legal precedent for such a move, referencing historical smallpox cases and questioning Alan Dershowitz's assertion that the government has the authority to "jab a needle in your arm."

The hosts discuss their personal vaccination statuses and challenge "pro-vaxxers" to get the HPV vaccine before criticizing others. They also explore "Fifth Disease" (slap-cheek), a viral rash caused by Parvovirus B19, noting the lack of a human vaccine for it despite its similarity to measles. The discussion centers on the selective nature of vaccine mandates and public health priorities.

A discussion regarding the requirement for children to receive 24 vaccinations by age three focuses on the logic of barring unvaccinated children from schools. Questions are raised about the efficacy of vaccines if vaccinated children are still considered at risk from their unvaccinated peers. The conversation touches on the lack of liability for drug companies and personal anecdotes regarding measles and chicken pox.

A 60 Minutes report on congressional insider trading features Nancy Pelosi's participation in a Visa IPO while credit card legislation was pending. Separately, Siga Technologies, owned by Democratic donor Ronald Perelman, received a $433 million no-bid contract for a smallpox drug. The hosts argue these stories indicate a coordinated effort to discredit the current political establishment.